158 related articles for article (PubMed ID: 1588554)
1. Nonpeptide renin inhibitors employing a novel 3-aza(or oxa)-2,4-dialkyl glutaric acid moiety as a P2/P3 amide bond replacement.
Baker WR; Fung AK; Kleinert HD; Stein HH; Plattner JJ; Armiger YL; Condon SL; Cohen J; Egan DA; Barlow JL
J Med Chem; 1992 May; 35(10):1722-34. PubMed ID: 1588554
[TBL] [Abstract][Full Text] [Related]
2. Renin inhibitors based on dipeptide analogues. Incorporation of the hydroxyethylene isostere at the P2/P3 sites.
Kempf DJ; de Lara E; Stein HH; Cohen J; Egan DA; Plattner JJ
J Med Chem; 1990 Jan; 33(1):371-4. PubMed ID: 2404121
[TBL] [Abstract][Full Text] [Related]
3. C-terminal modifications of nonpeptide renin inhibitors: improved oral bioavailability via modification of physicochemical properties.
Boyd SA; Fung AK; Baker WR; Mantei RA; Armiger YL; Stein HH; Cohen J; Egan DA; Barlow JL; Klinghofer V
J Med Chem; 1992 May; 35(10):1735-46. PubMed ID: 1588555
[TBL] [Abstract][Full Text] [Related]
4. Renin inhibitors based on novel dipeptide analogues. Incorporation of the dehydrohydroxyethylene isostere at the scissile bond.
Kempf DJ; de Lara E; Stein HH; Cohen J; Plattner JJ
J Med Chem; 1987 Nov; 30(11):1978-83. PubMed ID: 3312604
[TBL] [Abstract][Full Text] [Related]
5. Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases.
Li Z; Patil GS; Golubski ZE; Hori H; Tehrani K; Foreman JE; Eveleth DD; Bartus RT; Powers JC
J Med Chem; 1993 Oct; 36(22):3472-80. PubMed ID: 8230139
[TBL] [Abstract][Full Text] [Related]
6. Substrate analogue renin inhibitors containing replacements of histidine in P2 or isosteres of the amide bond between P3 and P2 sites.
Raddatz P; Jonczyk A; Minck KO; Schmitges CJ; Sombroek J
J Med Chem; 1991 Nov; 34(11):3267-80. PubMed ID: 1956045
[TBL] [Abstract][Full Text] [Related]
7. New potential renin inhibitors with dipeptide replacements in the molecule.
Winiecka I; Dudkiewicz-Wilczyńska J; Roman I; Paruszewski R
Acta Pol Pharm; 2010; 67(4):367-74. PubMed ID: 20635532
[TBL] [Abstract][Full Text] [Related]
8. New renin inhibitors containing pseudodipeptidic units in P3-P2 and P1-P1' positions.
Paruszewski R; Jaworski P; Bodnar M; Dudkiewicz-Wilczyńska J; Roman I
Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1305-9. PubMed ID: 16204988
[TBL] [Abstract][Full Text] [Related]
9. Discovery of non-peptidic P2-P3 butanediamide renin inhibitors with high oral efficacy.
Simoneau B; Lavallée P; Anderson PC; Bailey M; Bantle G; Berthiaume S; Chabot C; Fazal G; Halmos T; Ogilvie WW; Poupart MA; Thavonekham B; Xin Z; Thibeault D; Bolger G; Panzenbeck M; Winquist R; Jung GL
Bioorg Med Chem; 1999 Mar; 7(3):489-508. PubMed ID: 10220035
[TBL] [Abstract][Full Text] [Related]
10. Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.
Bolis G; Fung AK; Greer J; Kleinert HD; Marcotte PA; Perun TJ; Plattner JJ; Stein HH
J Med Chem; 1987 Oct; 30(10):1729-37. PubMed ID: 3309313
[TBL] [Abstract][Full Text] [Related]
11. Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'.
Raddatz P; Jonczyk A; Minck KO; Rippmann F; Schittenhelm C; Schmitges CJ
J Med Chem; 1992 Sep; 35(19):3525-36. PubMed ID: 1404233
[TBL] [Abstract][Full Text] [Related]
12. Structural modification of the P2' position of 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets.
Maibaum J; Stutz S; Göschke R; Rigollier P; Yamaguchi Y; Cumin F; Rahuel J; Baum HP; Cohen NC; Schnell CR; Fuhrer W; Gruetter MG; Schilling W; Wood JM
J Med Chem; 2007 Oct; 50(20):4832-44. PubMed ID: 17824680
[TBL] [Abstract][Full Text] [Related]
13. Novel small renin inhibitors containing 4,5- or 3,5-dihydroxy-2-substituted-6-phenylhexanamide replacements at the P2-P3 sites.
Jung GL; Anderson PC; Bailey M; Baillet M; Bantle GW; Berthiaume S; Lavallée P; Llinas-Brunet M; Thavonekham B; Thibeault D; Simoneau B
Bioorg Med Chem; 1998 Dec; 6(12):2317-36. PubMed ID: 9925293
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of human renin with C-termini derived from amides and esters of alpha-mercaptoalkanoic acids.
Ashton WT; Cantone CL; Tolman RL; Greenlee WJ; Lynch RJ; Schorn TW; Strouse JF; Siegl PK
J Med Chem; 1992 Jul; 35(15):2772-81. PubMed ID: 1495010
[TBL] [Abstract][Full Text] [Related]
15. Studies directed toward the design of orally active renin inhibitors. 2. Development of the efficacious, bioavailable renin inhibitor (2S)-2-benzyl-3- [[(1-methylpiperazin-4-yl)sulfonyl]propionyl]-3-thiazol-4-yl-L-alanine amide of (2S,3R,4S)-2-amino-1-cyclohexyl-3,4-dihydroxy-6-methylheptane (A-72517).
Rosenberg SH; Spina KP; Condon SL; Polakowski J; Yao Z; Kovar P; Stein HH; Cohen J; Barlow JL; Klinghofer V
J Med Chem; 1993 Feb; 36(4):460-7. PubMed ID: 8474102
[TBL] [Abstract][Full Text] [Related]
16. Novel renin inhibitors containing a non-peptide aminoalkanoyl moiety at P1-P1' position.
Winiecka I; Marszałek D; Goldnik A; Jaworski P; Mazurek AP
Pharmazie; 2014 Apr; 69(4):263-70. PubMed ID: 24791589
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
18. Novel 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamide transition state peptidomimetics are potent and orally active inhibitors of human renin.
Göschke R; Stutz S; Rasetti V; Cohen NC; Rahuel J; Rigollier P; Baum HP; Forgiarini P; Schnell CR; Wagner T; Gruetter MG; Fuhrer W; Schilling W; Cumin F; Wood JM; Maibaum J
J Med Chem; 2007 Oct; 50(20):4818-31. PubMed ID: 17824679
[TBL] [Abstract][Full Text] [Related]
19. Non-peptide renin inhibitors containing 2-(((3-phenylpropyl)phosphoryl)oxy)alkanoic acid moieties as P2-P3 replacements.
Raddatz P; Minck KO; Rippmann F; Schmitges CJ
J Med Chem; 1994 Feb; 37(4):486-97. PubMed ID: 8120867
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of human renin inhibitory peptides, angiotensinogen transition-state analogs containing a retro-inverso amide bond.
Harada H; Iizuka K; Kamijo T; Akahane K; Yamamoto R; Nakano Y; Tsubaki A; Kubota T; Shimaoka I; Umeyama H
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3042-7. PubMed ID: 2085885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
